Cerium Pharmaceuticals, Inc. — Form D
Cerium Pharmaceuticals, Inc. of GAITHERSBURG, MD, a company, filed a Form D exempt-offering notice with the SEC on 2021-07-30. The offering totals $10.1M, of which $8.9M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2021-07-30
- Form: D
- Accession: 0001677995-21-000004
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $10.1M
- Amount sold: $8.9M
- Remaining: $1.2M
- Minimum investment: $25K
- Investors: 5
- Date of first sale: 2021-07-22
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-408296
Issuer
- Name: Cerium Pharmaceuticals, Inc.
- CIK: 0001677995
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2012
- Address: 312 MAIN STREET SUITE 300, GAITHERSBURG, MD, 20878
- Phone: 703-229-2508
Officers, directors & promoters (11)
| Name | Role | Location |
|---|
| Thomas A DePasquale | Director | Gaithersburg, MD |
| James Gale | Director | Gaithersburg, MD |
| Gregg Lapointe | Director | Gaithersburg, MD |
| Nancy Klett | Executive Officer | Gaithersburg, MD |
| Gregg Lapointe | Executive Officer | Gaithersburg, MD |
| James Gale | Related Person | Gaithersburg, MD |
| Steve Eskenazi | Related Person | Gaithersburg, MD |
| Robert Rubin | Related Person | Gaithersburg, MD |
| Gregg A. Lapointe | Related Person | Gaithersburg, MD |
| Peter Collum | Related Person | Gaithersburg, MD |
| Tom DePasquale | Related Person | Gaithersburg, MD |
Other filings by this issuer (3)
More